Sign in

CIK 0001863127

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Tyra Biosciences, Inc.

Sign in to watch
Ticker
TYRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831476348
Phone
+1 619-728-4760
Business address
2656 STATE STREET, CARLSBAD, CA, 92008
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 4 Open-market buy 10% owner bought 125,000 shares at $13.12 ($1,640,313)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market buy Former 10% Owner bought 312,500 shares at $16.00 ($5,000,000)
  13. 4/A Conversion Director acquired 4,409,991 shares (conversion)
  14. 4 Conversion 10% owner acquired 4,409,991 shares (conversion)
  15. 4 Conversion Chief Operating Officer acquired 8,501 shares (conversion)
  16. 4 Open-market buy Director bought 156,250 shares at $16.00 ($2,500,000)
  17. 4 Open-market buy 10% owner bought 156,250 shares at $16.00 ($2,500,000)
  18. 4 Conversion Chief Financial Officer acquired 21,254 shares (conversion)
  19. 4 Conversion Chief Executive Officer acquired 34,007 shares (conversion)
  20. 4 Conversion Director acquired 61,444 shares (conversion)

Page 9 of 11 · 203 filings